A recent study published in the Journal of Human Hypertension investigates how adolescent body mass index (BMI) interacts with genetic predispositions to affect systolic blood pressure (SBP) in adulthood. By utilizing an extensive long-term dataset from 714 European participants, the research explores the impact of BMI during adolescence on genetic risk factors for high SBP in later life.
The study’s dataset includes blood samples taken at age 14 and saliva samples collected at ages 20 and 25, spanning multiple phases of growth (ages 12, 15, 17, 24, and 30). The researchers generated two genetic risk scores (GRS) based on genome-wide association studies (GWAS) to identify single-nucleotide polymorphisms (SNPs) linked to elevated SBP in adulthood. GRS182, which incorporated a broader range of SNPs than GRS22, was found to be a stronger predictor of SBP, explaining up to 5.6% of SBP variance in females, while it explained less than 1% in males.
Linear mixed models revealed a significant interaction between BMI and genetic risk, showing that higher BMI values (ranging from 22 kg/m² to 35 kg/m²) progressively enhanced the genetic predisposition to elevated SBP. However, this association was more pronounced in individuals with BMI values exceeding 22 kg/m² for females and 19 kg/m² for males. The study noted that while genetic factors played a more substantial role in explaining SBP variance in females, BMI had a stronger direct effect on SBP in males. The researchers emphasized the importance of early weight management to mitigate the long-term risk of high SBP and related complications.
Study Overview and Background
Hypertension, or high blood pressure, is a leading cause of preventable mortality, contributing to numerous chronic conditions such as cardiovascular diseases and kidney failure. Previous research has established strong links between high blood pressure in adolescents and an increased risk of hypertension in adulthood, highlighting the need for early intervention.
Genome-wide association studies have identified numerous genetic variants associated with elevated blood pressure, but their impact on adolescents remains poorly understood. The International Consortium for Blood Pressure (ICBP) has uncovered hundreds of SNPs related to high blood pressure, but a gap exists in understanding how these genetic factors influence blood pressure during youth. This study aims to address this gap by examining whether adolescent BMI can modify the relationship between genetic risk and high SBP in adulthood.
Methodology
The study’s participants were sourced from the Nicotine Dependence in Teens (NDIT) study, a longitudinal project initiated in 1999-2000 that tracked 1,294 students from secondary schools in Montreal. The participants, all of European descent, were followed up at ages 12, 14, 15, 17, 20, 24, 30, and 34. Along with questionnaires and physical measurements, blood and saliva samples were collected at various stages.
Using genotyping data for 636,454 SNPs, the researchers created two genetic risk scores, GRS22 and GRS182, based on SNPs linked to adult SBP. The study employed linear mixed models to assess the interactions between BMI and genetic risk in predicting SBP outcomes, with an emphasis on sex-specific differences. The study also included a leave-one-out method to refine the accuracy of the GRS182.
Key Findings
The study found that both BMI and genetic risk contributed to elevated SBP, but no direct link was identified between BMI and specific genetic variants. This suggests that BMI and genetic factors may influence blood pressure via different biological mechanisms. Notably, genetic risk scores were a more significant predictor of SBP in females, explaining up to 5.6% of SBP variance. In contrast, BMI had a more pronounced effect on SBP in males.
The study also found that BMI amplified the association between genetic risk and SBP at higher BMI levels—specifically, above 22 kg/m² for females and 19 kg/m² for males. This highlights the importance of monitoring BMI during adolescence to mitigate the impact of genetic predispositions on blood pressure.
Limitations and Clinical Implications
While the study provides valuable insights, it is not without limitations. The sample size of 714 participants may have limited the detection of subtle genetic effects, and the exclusive focus on individuals of European descent raises questions about the generalizability of the findings to more diverse populations. Future research should explore whether these results apply to other ethnic groups.
Despite these limitations, the findings underscore the critical role of BMI in modulating the genetic risk for high SBP. The study suggests that early interventions targeting BMI through diet and exercise could significantly reduce the risk of hypertension in later life, particularly for individuals with a genetic predisposition to elevated blood pressure.
Conclusion
This study demonstrates that adolescent BMI can exacerbate genetic predispositions to high systolic blood pressure in adulthood, with notable sex-specific differences. The findings advocate for early weight management and intervention strategies to prevent the long-term health risks associated with high blood pressure. By understanding the interplay between genetic risk and BMI, the study paves the way for more targeted approaches in preventing hypertension and related diseases.
Related topic:
COVID-19 Pandemic Causes Significant Life Expectancy Loss, Study Shows
Better Heart Health May Lower Neurodegenerative Risk
New Finnish Study Challenges Exercise and Longevity Link
